UBS Group’s Therapix Biosciences Ltd. TRPX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-41,428
| Closed | -$26K | – | 7773 |
|
|
2020
Q2 | $26K | Buy |
41,428
+35,962
| +658% | +$22.6K | ﹤0.01% | 5548 |
|
|
2020
Q1 | $2K | Buy |
5,466
+3,576
| +189% | +$1.31K | ﹤0.01% | 6772 |
|
|
2019
Q4 | $2K | Buy |
1,890
+1,559
| +471% | +$1.65K | ﹤0.01% | 6819 |
|
|
2019
Q3 | $1K | Buy |
+331
| New | +$1K | ﹤0.01% | 6941 |
|
|
2019
Q1 | – | Sell |
-4,612
| Closed | -$15K | – | 7313 |
|
|
2018
Q4 | $15K | Buy |
4,612
+3,030
| +192% | +$9.86K | ﹤0.01% | 6086 |
|
|
2018
Q3 | $7K | Buy |
1,582
+1,109
| +234% | +$4.91K | ﹤0.01% | 6448 |
|
|
2018
Q2 | $2K | Sell |
473
-2,427
| -84% | -$10.3K | ﹤0.01% | 6833 |
|
|
2018
Q1 | $17K | Buy |
+2,900
| New | +$17K | ﹤0.01% | 5652 |
|
|
2017
Q2 | – | Sell |
-230
| Closed | -$2K | – | 6988 |
|
|
2017
Q1 | $2K | Buy |
+230
| New | +$2K | ﹤0.01% | 6401 |
|